WDR65 Activators constitute a class of chemical compounds recognized for their capability to modulate the activity of the WDR65 gene. WDR65, also known as WD Repeat Domain 65, is a gene that encodes a protein whose functions are still being explored within the realm of molecular biology. Activators of WDR65 are molecules that possess the capacity to either enhance the expression of the WDR65 gene or augment its biological activity within a cell. These compounds serve as valuable tools for researchers aiming to decipher the biological significance of WDR65 and its potential involvement in various cellular processes.
The specific mechanisms by which WDR65 activators exert their effects are currently a subject of active scientific investigation. These molecules may act at the transcriptional or post-transcriptional level, potentially influencing the production of WDR65 protein or modifying its interactions with other cellular components. By manipulating WDR65 activity, researchers aim to unravel its biological functions, which may include roles in cellular signaling, molecular pathways, or cellular responses to internal or external stimuli. Exploring WDR65 activators offers the promise of shedding light on the molecular pathways and cellular processes governed by this gene, thereby advancing our understanding of its significance in normal cellular physiology and potentially leading to novel insights in fields such as molecular biology and genetics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid receptor agonist, can regulate gene expression which may lead to changes in the expression levels of genes such as WDR65. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone, an antagonist of the aldosterone receptor, may alter gene expression profiles that could include modulation of WDR65 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, a histone deacetylase inhibitor, can affect chromatin remodeling and potentially influence the expression of various genes including WDR65. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an activator of AMP-activated protein kinase (AMPK) that can lead to transcriptional changes, possibly affecting WDR65 expression. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which could indirectly modulate gene expression patterns, potentially impacting WDR65 levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which may result in a broad change in gene expression that could hypothetically upregulate WDR65. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is an inhibitor of the TGF-β receptor, potentially leading to altered gene expression that may include WDR65 upregulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which could affect downstream signaling pathways, possibly influencing the expression of WDR65. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that may alter signaling pathways, leading to changes in gene expression potentially affecting WDR65. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to Hsp90, which may affect the stability and function of client proteins, potentially altering WDR65 expression. | ||||||